An independently-owned and operated research company, RCA specializes in conducting Phase I-IV CNS trials for pharmaceutical and biotech companies. We are committed to delivering solid science and apply strict adherence to GCP/ICH, as well as training in FDA Code of Federal Regulations. Committed to the integrity and quality of our work, RCA delivers accurate results and aim to exceed our goals in medical advancement.